# Pharmaceutical products (HS2 30) Sector Trade Overview | Yugalinks

> Published by **Yugalinks**, global trade intelligence for growing businesses.
>
> [Follow Yugalinks on LinkedIn](https://in.linkedin.com/company/yugalinks)

Pharmaceutical products at HS2 30, with reported global trade through 2024.

Canonical: https://www.yugalinks.com/trade/sector/hs2/30

## Answer

The pharmaceutical products sector recorded $900.6B in reported global trade in 2024, with +25.6% annual change.

## Key figures

| Measure | Value |
| --- | --- |
| Latest reported trade | $900.6B |
| Latest annual change | +25.6% |
| Active exporters | 198 |
| Active importers | 200 |
| Active HS6 products | 43 |

## Annual trend

| Year | Global trade | Corridors | HS6 products |
| --- | ---: | ---: | ---: |
| 1995 | $55.5B | 8,209 | 39 |
| 1996 | $60.6B | 8,223 | 39 |
| 1997 | $66.9B | 8,279 | 39 |
| 1998 | $75.7B | 8,498 | 39 |
| 1999 | $94.8B | 8,985 | 39 |
| 2000 | $99.9B | 10,107 | 39 |
| 2001 | $122.3B | 10,351 | 39 |
| 2002 | $152.3B | 10,295 | 39 |
| 2003 | $188.2B | 10,537 | 39 |
| 2004 | $227.2B | 10,825 | 39 |
| 2005 | $251.5B | 11,069 | 39 |
| 2006 | $290.6B | 11,339 | 39 |
| 2007 | $347.7B | 11,591 | 39 |
| 2008 | $401.0B | 11,601 | 39 |
| 2009 | $422.9B | 11,882 | 39 |
| 2010 | $418.4B | 12,012 | 39 |
| 2011 | $451.7B | 12,349 | 39 |
| 2012 | $451.2B | 12,598 | 44 |
| 2013 | $467.9B | 12,610 | 44 |
| 2014 | $496.5B | 12,960 | 44 |
| 2015 | $475.8B | 13,055 | 44 |
| 2016 | $496.2B | 13,186 | 44 |
| 2017 | $528.8B | 13,293 | 44 |
| 2018 | $592.0B | 13,510 | 44 |
| 2019 | $623.5B | 13,533 | 44 |
| 2020 | $681.6B | 13,742 | 44 |
| 2021 | $820.8B | 14,010 | 44 |
| 2022 | $833.8B | 14,119 | 43 |
| 2023 | $842.3B | 14,024 | 43 |
| 2024 | $900.6B | 14,007 | 43 |

## Growth and market structure

- Trend: Growing
- Three-year CAGR: +3.1%
- Five-year CAGR: +7.6%
- Historical peak: $900.6B in 2,024
- Positive-growth years: 89.7%
- Exporter concentration HHI: 1,979
- Importer concentration HHI: 1,551.3
- Trade volatility coefficient: 0.6

## Leading corridors

| Rank | Exporter | Importer | Trade value | Growth | HS6 products | Distance | FTA |
| ---: | --- | --- | ---: | ---: | ---: | ---: | --- |
| 1 | Ireland | USA, Puerto Rico and US Virgin Islands | $41.6B | +8.7% | 33 | 5,129 km | No |
| 2 | Switzerland, Liechtenstein | USA, Puerto Rico and US Virgin Islands | $28.4B | +1.3% | 31 | 6,339 km | No |
| 3 | Germany | USA, Puerto Rico and US Virgin Islands | $23.8B | +2.7% | 35 | 6,402 km | No |
| 4 | Slovenia | Switzerland, Liechtenstein | $20.4B | +82.9% | 19 | 481 km | Yes |
| 5 | Belgium | USA, Puerto Rico and US Virgin Islands | $14.9B | +11.8% | 35 | 5,904 km | No |
| 6 | Italy | USA, Puerto Rico and US Virgin Islands | $12.4B | +29.8% | 36 | 6,907 km | No |
| 7 | Singapore | USA, Puerto Rico and US Virgin Islands | $11.6B | +36.4% | 26 | 15,347 km | Yes |
| 8 | Switzerland, Liechtenstein | Germany | $11.5B | -0.4% | 37 | 674 km | Yes |
| 9 | USA, Puerto Rico and US Virgin Islands | Germany | $11.2B | +10.3% | 35 | 6,402 km | No |
| 10 | India | USA, Puerto Rico and US Virgin Islands | $10.7B | +10.8% | 37 | 11,771 km | No |

## Leading exporters

| Rank | Country | Exports | Partners | HS6 products |
| ---: | --- | ---: | ---: | ---: |
| 1 | Germany | $119.5B | 190 | 43 |
| 2 | Ireland | $99.9B | 168 | 42 |
| 3 | Switzerland, Liechtenstein | $97.2B | 184 | 43 |
| 4 | USA, Puerto Rico and US Virgin Islands | $95.0B | 191 | 43 |
| 5 | Italy | $58.3B | 178 | 43 |
| 6 | Belgium | $55.1B | 189 | 43 |
| 7 | France | $40.2B | 192 | 43 |
| 8 | Netherlands | $32.8B | 194 | 43 |
| 9 | Slovenia | $28.6B | 143 | 42 |
| 10 | United Kingdom | $27.3B | 192 | 43 |

## Leading importers

| Rank | Country | Imports | Partners | HS6 products |
| ---: | --- | ---: | ---: | ---: |
| 1 | USA, Puerto Rico and US Virgin Islands | $209.3B | 140 | 43 |
| 2 | Germany | $71.5B | 150 | 43 |
| 3 | Switzerland, Liechtenstein | $62.9B | 138 | 43 |
| 4 | Belgium | $44.0B | 142 | 43 |
| 5 | China | $39.1B | 114 | 43 |
| 6 | Netherlands | $37.0B | 140 | 43 |
| 7 | Italy | $31.1B | 97 | 43 |
| 8 | France | $30.9B | 167 | 43 |
| 9 | United Kingdom | $29.9B | 135 | 43 |
| 10 | Japan | $28.3B | 88 | 43 |

## HS6 products

- Glands and other organs: dried, whether or not powdered (HS6 300110)
- Glands and other organs: extracts of glands or other organs or of their secretions, for organo-therapeutic uses (HS6 300120)
- Glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001 (HS6 300190)
- Blood: human or animal, antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes (HS6 300210)
- Blood, human or animal, antisera, other blood fractions and immunological products: malaria diagnostic test kits (HS6 300211)
- Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions (HS6 300212)
- Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale (HS6 300213)
- Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale (HS6 300214)
- Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale (HS6 300215)
- Blood, human or animal, antisera, other blood fractions and immunological products: n.e.c. in heading 3002.1 (HS6 300219)
- Vaccines: for human medicine (HS6 300220)
- Vaccines: for veterinary medicine (HS6 300230)
- Vaccines: for veterinary medicine, against foot and mouth disease (HS6 300231)
- Vaccines: for veterinary medicine, for other uses than against foot and mouth disease (HS6 300239)
- Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: for human medicine (HS6 300241)
- Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: for veterinary medicine (HS6 300242)
- Toxins, cultures of micro-organisms (excluding yeasts) and similar products: n.e.c. in item 3002.3 (HS6 300249)
- Cell cultures, whether or not modified: cell therapy products (HS6 300251)
- Cell cultures, whether or not modified: other cell cultures not including cell therapy products (HS6 300259)
- Toxins, cultures of micro-organisms (excluding yeasts) and similar products (HS6 300290)
- Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale) (HS6 300310)
- Medicaments: containing antibiotics other than penicillins, streptomycins and their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale) (HS6 300320)
- Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale (HS6 300331)
- Medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale (HS6 300339)
- Medicaments: containing alkaloids or their derivatives, (but not containing hormones or antibiotics), for therapeutic or prophylactic uses, (not packaged for retail sale) (HS6 300340)
- Medicaments: containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale) (HS6 300341)
- Medicaments: containing alkaloids or their derivatives, containing pseudoephedrine (INN) or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale) (HS6 300342)
- Medicaments: containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale) (HS6 300343)
- Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, (not packaged for retail sale) (HS6 300349)
- Medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, (not packaged for retail sale) (HS6 300360)
- Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) (HS6 300390)
- Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300410)
- Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale (HS6 300420)
- Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300431)
- Medicaments: containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale (HS6 300432)
- Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300439)
- Medicaments: containing alkaloids or their derivatives (but not hormones or antibiotics), for therapeutic or prophylactic uses, packaged for retail sale (HS6 300440)
- Medicaments: containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300441)
- Medicaments: containing alkaloids or their derivatives, containing pseudoephedrine (INN) or its salts, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300442)
- Medicaments: containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300443)
- Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale (HS6 300449)
- Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale (HS6 300450)
- Medicaments: containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300460)
- Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300490)
- Dressings, adhesive: and other articles having an adhesive layer, packed for retail sale for medical, surgical, dental or veterinary purposes (HS6 300510)
- Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale (HS6 300590)
- Pharmaceutical goods: sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents, absorbable surgical or dental haemostatics, and surgical or dental adhesion barriers (HS6 300610)
- Pharmaceutical goods: blood-grouping reagents (HS6 300620)
- Pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient (HS6 300630)
- Pharmaceutical goods: dental cements and other dental fillings, bone reconstruction cements (HS6 300640)
- Pharmaceutical goods: first aid boxes and kits (HS6 300650)
- Pharmaceutical goods: chemical contraceptive preparations based on hormones or spermicides (HS6 300660)
- Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments (HS6 300670)
- Pharmaceutical goods: waste pharmaceuticals (HS6 300680)
- Pharmaceutical goods: appliances identifiable for ostomy use (HS6 300691)
- Pharmaceutical goods: waste pharmaceuticals (HS6 300692)
- Pharmaceutical goods: placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses (HS6 300693)

## Definitions and coverage

Merchandise trade observations aggregated to HS2. Growth, concentration, volatility, and peak comparisons calculated from reported observations. Missing values remain unavailable and are not imputed.

Reported observations cover 1995-2024. The data release was refreshed 2026-07-20 09:34:08.

## Other formats

- [HTML](https://www.yugalinks.com/trade/sector/hs2/30/index.html)
- [JSON](https://www.yugalinks.com/trade/sector/hs2/30/index.json)
- [JSON-LD](https://www.yugalinks.com/trade/sector/hs2/30/index.ld.json)

## About Yugalinks

Yugalinks provides practical trade intelligence for teams evaluating markets, suppliers, and routes. Visit [Yugalinks](https://www.yugalinks.com) or [follow Yugalinks on LinkedIn](https://in.linkedin.com/company/yugalinks).


## Explore Yugalinks

- [Open the trade workspace](https://www.yugalinks.com/app)
- [Read the methodology](https://www.yugalinks.com/methodology)
- [Review data sources](https://www.yugalinks.com/data-sources)
- [Check data coverage](https://www.yugalinks.com/data-coverage)
- [Read Responsible AI principles](https://www.yugalinks.com/responsible-ai)

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-27). [OECD Data Explorer](https://data-explorer.oecd.org/) · [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) · [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) · [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.